[EPISODE 19] Tricia Sterling Talks Rare Diseases, Trust, and Advocacy

In this episode of Molecular Moments, Dr. Jim McNally chats with Tricia Sterling, Vice President of Patient Affairs at Aeglea. Tricia shares some of her experiences working with patients in the biotech industry for over a decade.

Jim and Tricia’s discussion focuses on the patient side of pharmaceutical research, particularly in relation to rare diseases, as they affect 1 out of 15 people worldwide. They discuss the patient journey, creating better clinical trial experiences, and the importance of giving families hope. Tricia shares how patient advocacy starts with transparency and trust between patients, caregivers, and pharmaceutical companies.